Benjamin J. Golas, M.D.

Benjamin Golas

 Benjamin J. Golas, MD, is an Assistant Professor of Surgery and an Assistant Attending Surgeon at NewYork-Presbyterian/Weill Cornell Medical Center.  Dr. Golas is an experienced, board-certified surgeon specializing in surgical oncology, including minimally-invasive procedures for liver cancer, liver metastases, pancreatic cancer, and other gastrointestinal malignancies.  He offers unique expertise in novel treatments for liver tumors, including radiofrequency ablation.

Dr. Golas received his MD from the Georgetown University School of Medicine in Washington, DC, where he graduated Magna Cum Laude and was elected to the Alpha Omega Alpha Honor Medical Society.  He did his residency in general surgery at New York-Presbyterian Hospital/Weill Cornell Medical Center, serving as the Chief Surgical Resident.  He completed a fellowship in Surgical Oncology with a focus in liver and pancreatic surgery at the University of Pittsburgh Medical Center.  Dr. Golas also completed a research fellowship in the Laboratory of Epithelial Cancer Biology at Memorial Sloan-Kettering Cancer Center.  Before joining NYP/Weill Cornell faculty, Dr. Golas was a Clinical Instructor in Surgery at the University of Pittsburgh Medical Center.  He is a member of several prestigious medical societies, including the Society of Surgical Oncology and the Americas Hepato-Pancreato-Biliary Association. He has received several honors, including the Distinguished Housestaff Award from the Weill Cornell Alumni Council and  is also a member of  Phi Beta Kappa.  Dr. Golas has published in multiple scientific journals, was a contributing editor for General Surgery Review, and authored a chapter entitled "Laparoscopic Liver Resection in the treatment of Hepatocellular Carcinoma and Colorectal Cancer Liver Metastases." He has presented at many national scientific conferences across the country on minimally-invasive surgery for hepatobiliary cancer and advanced surgical treatment for colorectal cancer liver metastases.

 

 

 

 

Insurances

Insurance Plans Accepted

The following represents most of the managed care plans accepted by this physician. If your insurance carrier does not appear here please feel free to contact this physician or this physician's practice as they may have individual contracts not included on this site.

  • AETNA [PPO]
  • AETNA [Medicare]
  • AETNA [HMO]
  • Aetna - Weill Cornell [POS]
  • Affinity Essential
  • Affinity Health Plan
  • Blue Priority Network
  • CIGNA
  • Emblem Select Care
  • Empire Blue Cross/Blue Shield [Pathway X]
  • Empire Blue Cross/Blue Shield [Pathway X Enhanced]
  • Empire Blue Cross/Blue Shield [PPO]
  • Empire Blue Cross/Blue Shield [Mediblue (Senior)]
  • Empire Blue Cross/Blue Shield [HMO]
  • Empire Blue Cross/Blue Shield [EPO]
  • Fidelis Care
  • GHI [CBP]
  • Health First
  • Health Insurance Plan of NY (HIP) [Medicaid]
  • Health Insurance Plan of NY (HIP) [Medicare]
  • Health Insurance Plan of NY (HIP)
  • Health Plus - Amerigroup [CHP]
  • Health Plus - Amerigroup
  • Oxford Health Plans [Liberty]
  • Oxford Health Plans [Medicare Advantage]
  • Oxford Health Plans [Freedom]
  • POMCO
  • Rockefeller University - CoreSource
  • United Empire
  • United Health Care [Medicare]
  • United Health Care
  • United Health Care [Community Plan]
  • VNSNY CHOICE Medicare [Medicare]
  • VNSNY CHOICE Medicare [HMO]

Publications

Publications:

  1. Bronzino JD, Kehoe P, Hendriks R, Vita L, Golas B, Vivona C, Morgane PJ.  Hippocampal Neurochemical and Electrophysiological Measures from Freely Moving Rats.  Experimental Neurology 1999; 150-155.
  2. Marks JL, Golas B, Kirchoff T, Miller VA, Riely GJ, Offit K, Pao W.  EGFR mutant lung adenocarcinomas in patients with germline BRCA mutations.  J Thorac Oncol. 2008 Jul;3(7):805.
  3. Marks JL, Gong Y, Chitale D, Golas B, McLellan MD, Kasai Y, Ding L, Mardis ER, Wilson RK, Solit D, Levine R, Michel K, Thomas RK, Rusch VW, Ladanyi M, Pao W.  Novel MEK1 mutation identified by mutational analysis of epidermal growth factor receptor signaling pathway genes in lung adenocarcinoma.  Cancer Res. 2008 Jul 15;68(14):5524-8.
  4. Chitale D, Gong Y, Taylor BS, Broderick S, Brennan C, Somwar R, Golas B, Wang L, Motoi N, Szoke J, Reinersman JM, Major J, Sander C, Seshan VE, Zakowski MF, Rusch V, Pao W, Gerald W, Ladanyi M.  An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors.  Oncogene. 2009 Aug 6;28(31):2773-83.
  5. Broderick SR*, Golas BJ*, Pham D*, Towe CW*, Talbot SG, Bains S, Huryn LA, Yonekawa Y, Carlson D, Hambardzumyan D, Ramanathan Y, and Singh B.  SCCRO Promotes Glioma Formation and Malignant Progression in Mice.  Neoplasia. 2010 June: 12(6):476-484(*equal contributors).

 

Books, book chapters and reviews. 

1. Golas B., Contributing Editor.  General Surgery Review.  Washington, DC; Ladner-Drysdale; 2004.

2.  Geller DA, Tsung AA, Golas BJ. "Laparoscopic Liver Resection in the Treatment of Hepatocellular Carcinoma and Colorectal Cancer Liver Metastases" (update). In: Brunicardi FC, Andersen DK, Billiar TR, Dunn DL, Hunter JG, Matthews JB, Pollock RE, eds. Schwartz's Principles of Surgery. 9th ed. New York: McGraw-Hill; 2011

Abstracts

1. Golas B., SCCRO Promotes Glioma Formation and Malignant Progression in Mice, Memorial Sloan-Kettering Cancer Center; New York, NY; 2008. 

2. Golas B., The Role of SCCRO in Gliomagenesis.  Society of University Surgeons.  Huntington Beach, CA; 2008. 

3. Mejia J.C., Marsh J.W., Steele J., Golas B.J., Humar A., Zeh H., Geller D.A, Tsung A., Indications and Outcomes of Pancreas Surgery After Liver Transplantation, Americas Hepato-Pancreato-Biliary Association, Miami, FL; 2/2013.

4. Golas B.J., Marsh J.W., Mejia J.C., Gamblin T.C., Tsung A., Geller D.A., Five and Ten Year Survival in Patients Undergoing Radiofrequency Ablation for Primary and Secondary Hepatic Malignancies, Americas Hepato-Pancreato-Biliary Association, Miami, FL; 2/22/2013.

5. Golas B.J., Li S., Reddy S.K., Steele J., Mejia J.C., Pingpank J.F., Marsh, J.W., Bartlett D., Geller, D.A, Tsung, A., Oral Presentation, Minimally Invasive Resection of Colorectal Cancer Liver Metastases Shortens the Interval to Initiation of Adjuvant Systemic Chemotherapy: A Case-Control Study, Americas Hepato-Pancreato-Biliary Association, Miami, FL; 2/24/2013.

6. Golas, Benjamin J.; Magge, Deepa; Zureikat, Amer H.; Zeh, Herbert J.; Alexander, Henry R.; Libutti, Steven K.; Royal, Richard E.; Holtzman, Matthew P.; Hughes, Marybeth S.; Turaga, Kiran K.; Pappas, Sam G.; Gamblin, T Clark; Bartlett, David L.; Pingpank, James F., Analysis of Toxicity and Outcomes in Patients Undergoing Hyperthermic Isolated Hepatic Perfusion with Melphalan for Metastatic Melanoma to the Liver, Society of Surgical Oncology, Washington DC; 3/7/2013.

 

Presentations:

1. Golas B., SCCRO Promotes Glioma Formation and Malignant Progression in Mice, Memorial Sloan-Kettering Cancer Center; New York, NY; 2008. 

2. Golas B., The Role of SCCRO in Gliomagenesis.  Society of University Surgeons.  Huntington Beach, CA; 2008. 

3. Mejia J.C., Marsh J.W., Steele J., Golas B.J., Humar A., Zeh H., Geller D.A, Tsung A., Indications and Outcomes of Pancreas Surgery After Liver Transplantation, Americas Hepato-Pancreato-Biliary Association, Miami, FL; 2/2013.

4. Golas B.J., Marsh J.W., Mejia J.C., Gamblin T.C., Tsung A., Geller D.A., Five and Ten Year Survival in Patients Undergoing Radiofrequency Ablation for Primary and Secondary Hepatic Malignancies, Americas Hepato-Pancreato-Biliary Association, Miami, FL; 2/22/2013.

5. Golas B.J., Li S., Reddy S.K., Steele J., Mejia J.C., Pingpank J.F., Marsh, J.W., Bartlett D., Geller, D.A, Tsung, A., Oral Presentation, Minimally Invasive Resection of Colorectal Cancer Liver Metastases Shortens the Interval to Initiation of Adjuvant Systemic Chemotherapy: A Case-Control Study, Americas Hepato-Pancreato-Biliary Association, Miami, FL; 2/24/2013.

6. Golas, Benjamin J.; Magge, Deepa; Zureikat, Amer H.; Zeh, Herbert J.; Alexander, Henry R.; Libutti, Steven K.; Royal, Richard E.; Holtzman, Matthew P.; Hughes, Marybeth S.; Turaga, Kiran K.; Pappas, Sam G.; Gamblin, T Clark; Bartlett, David L.; Pingpank, James F., Analysis of Toxicity and Outcomes in Patients Undergoing Hyperthermic Isolated Hepatic Perfusion with Melphalan for Metastatic Melanoma to the Liver, Society of Surgical Oncology, Washington DC; 3/7/2013.

Honors and Awards

  1. Alpha Omega Alpha, 3/2003
  2. Phi Beta Kappa; Trinity College, 4/1997
  3. New York Weill Cornell Medical Center Alumni Council Distinguished Housestaff Award, 11/2010
  4. Society of Thoracic Surgeons “Looking to the Future” scholarship award; 2/2008
  5. Dr. James A. Cahill Award for Excellence in Surgery; Georgetown University School of Medicine; 5/2004
  6. Neuroscience Fellow; Trinity College; 1/1997 (awarded to top student in major)